ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

HEPLISAV-B
Vaccines
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

HEPLISAV-B Rx

Generic Name and Formulations:
Hepatitis B vaccine (recombinant), adjuvanted (formulated to contain HBsAg 20mcg + CpG 1018 3000mcg) per 0.5mL dose; soln for IM inj; preservative-free.

Company:
Dynavax Technologies

Therapeutic Use:

Indications for HEPLISAV-B:

Hepatitis B immunization.

Adult:

Give IM inj in deltoid muscle. ≥18yrs: 2 doses (0.5mL each) 1 month apart.

Children:

<18yrs: not established.

Contraindications:

Yeast hypersensitivity.

Warnings/Precautions:

Have appropriate medical treatment available to manage possible anaphylactic reactions. Immunocompromised. Pregnancy. Nursing mothers.

Pharmacological Class:

HB.

Interactions:

Concomitant immunosuppressants: may get sub-optimal response. Concomitant immune globulin; give separately using different syringes at different inj sites. May interfere with lab tests.

Adverse Reactions:

Local reactions (eg, pain, redness, swelling), fatigue, headache, malaise; anaphylaxis.

Note:

To register pregnant patients, call (844) 443-7734.

Generic Availability:

NO

How Supplied:

Single-dose vials—1, 5

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs